RXFP4 (rl3r2_human)
FAMILY
Class A (Rhodopsin) Peptide receptors Relaxin family peptide receptors RXFP4
GENE
RXFP4 (GPCR142, GPR100, RLN3R2)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Relaxin-3 receptor 2, RLN3 receptor 2, G-protein coupled receptor 100, G-protein coupled receptor GPCR142, Insulin-like peptide INSL5 receptor, Relaxin family peptide receptor 4
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
P
|
T
|
L
|
N
|
T
|
S
|
A
|
S
|
P
|
10 |
P
|
T
|
F
|
F
|
W
|
A
|
N
|
A
|
S
|
G
|
20 |
G
|
S
|
V
|
L
|
S
|
A
|
D
|
D
|
A
|
P
|
30 |
TM1 | |||||||||
M
|
P
|
V
|
K
|
F
|
L
|
A
|
L
|
R
|
L
|
40 |
M
|
V
|
A
|
L
|
A
|
Y
|
G
|
L
|
V
|
G
|
50 |
A
|
I
|
G
|
L
|
L
|
G
|
N
|
L
|
A
|
V
|
60 |
L
|
W
|
V
|
L
|
S
|
N
|
C
|
A
|
R
|
R
|
70 |
ICL1 | TM2 | ||||||||
A
|
P
|
G
|
P
|
P
|
S
|
D
|
T
|
F
|
V
|
80 |
F
|
N
|
L
|
A
|
L
|
A
|
D
|
L
|
G
|
L
|
90 |
A
|
L
|
T
|
L
|
P
|
F
|
W
|
A
|
A
|
E
|
100 |
ECL1 | |||||||||
S
|
A
|
L
|
D
|
F
|
H
|
W
|
P
|
F
|
G
|
110 |
TM3 | |||||||||
G
|
A
|
L
|
C
|
K
|
M
|
V
|
L
|
T
|
A
|
120 |
T
|
V
|
L
|
N
|
V
|
Y
|
A
|
S
|
I
|
F
|
130 |
L
|
I
|
T
|
A
|
L
|
S
|
V
|
A
|
R
|
Y
|
140 |
ICL2 | |||||||||
W
|
V
|
V
|
A
|
M
|
A
|
A
|
G
|
P
|
G
|
150 |
TM4 | |||||||||
T
|
H
|
L
|
S
|
L
|
F
|
W
|
A
|
R
|
I
|
160 |
A
|
T
|
L
|
A
|
V
|
W
|
A
|
A
|
A
|
A
|
170 |
L
|
V
|
T
|
V
|
P
|
T
|
A
|
V
|
F
|
G
|
180 |
ECL2 | |||||||||
V
|
E
|
G
|
E
|
V
|
C
|
G
|
V
|
R
|
L
|
190 |
C
|
L
|
L
|
R
|
F
|
P
|
S
|
R
|
Y
|
W
|
200 |
TM5 | |||||||||
L
|
G
|
A
|
Y
|
Q
|
L
|
Q
|
R
|
V
|
V
|
210 |
L
|
A
|
F
|
M
|
V
|
P
|
L
|
G
|
V
|
I
|
220 |
T
|
T
|
S
|
Y
|
L
|
L
|
L
|
L
|
A
|
F
|
230 |
ICL3 | TM6 | |||||||||
L
|
Q
|
R
|
R
|
Q
|
R
|
R
|
R
|
Q
|
D
|
|
240 |
S
|
R
|
V
|
V
|
A
|
R
|
S
|
V
|
R
|
I
|
250 |
L
|
V
|
A
|
S
|
F
|
F
|
L
|
C
|
W
|
F
|
260 |
P
|
N
|
H
|
V
|
V
|
T
|
L
|
W
|
G
|
V
|
270 |
ECL3 | |||||||||
L
|
V
|
K
|
F
|
D
|
L
|
V
|
P
|
W
|
N
|
280 |
TM7 | |||||||||
S
|
T
|
F
|
Y
|
T
|
I
|
Q
|
T
|
Y
|
V
|
290 |
F
|
P
|
V
|
T
|
T
|
C
|
L
|
A
|
H
|
S
|
300 |
N
|
S
|
C
|
L
|
N
|
P
|
V
|
L
|
Y
|
C
|
310 |
H8 | |||||||||
L
|
L
|
R
|
R
|
E
|
P
|
R
|
Q
|
A
|
L
|
320 |
A
|
G
|
T
|
F
|
R
|
D
|
L
|
R
|
L
|
R
|
330 |
C-term | |||||||||
L
|
W
|
P
|
Q
|
G
|
G
|
G
|
W
|
V
|
Q
|
340 |
Q
|
V
|
A
|
L
|
K
|
Q
|
V
|
G
|
R
|
R
|
350 |
W
|
V
|
A
|
S
|
N
|
P
|
R
|
E
|
S
|
R
|
360 |
P
|
S
|
T
|
L
|
L
|
T
|
N
|
L
|
D
|
R
|
370 |
G
|
T
|
P
|
G
|
DIAGRAMS
7TM
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
relaxin-3, relaxin-3 (B chain), INSL5
STRUCTURE MODELS
STRUCTURES
Found 3 structure(s) - view all details on the Structures page